Dr. Lawrence E. Feldman
Claim this profileUniversity of Illinois
About Lawrence E. Feldman
Education:
- Earned an MD from the University of Michigan College of Medicine.
- Completed Residency, Internship, and Fellowship at the University of Michigan Medical School.
Experience:
- Board Certified by the American Board of Internal Medicine and American Board of Medical Oncology.
- Specializes in lung, head, and neck cancers at UI Health's Division of Hematology & Oncology.
- Leads research focused on early detection and immunotherapy.
- Active member of the Translational Oncology Program at the University of Illinois.
Area of expertise
Lung Cancer
Lawrence E. Feldman has run 21 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Lawrence E. Feldman has run 12 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Illinois
Jesse Brown Veterans Affairs Medical Center
Clinical Trials Lawrence E. Feldman is currently running
ADT + Pembrolizumab
for Salivary Gland Cancer
A Phase II, multi-center, single-arm, non-blinded study combining androgen deprivation therapy (ADT) and pembrolizumab for patients with metastatic or locally recurrent androgen receptor-positive salivary gland carcinoma, not amenable to surgery or radiation.
Recruiting
1 award
Phase 2
21 criteria
Cabozantinib + Pembrolizumab
for Lung Cancer
This is a phase II study to assess the efficacy, safety, and Health Related Quality of Life (HRQoL) of combination cabozantinib and pembrolizumab as maintenance therapy for patients with metastatic squamous Non Small Cell Lung Cancer(sqNSCLC) who have received 4 cycles of induction therapy with pembrolizumab, carboplatin, and nab-paclitaxel or paclitaxel.
Recruiting
1 award
Phase 2
More about Lawrence E. Feldman
Clinical Trial Related
6 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Lawrence E. Feldman has experience with
- Pembrolizumab
- Carboplatin
- Nivolumab
- Atezolizumab
- Cisplatin
- Docetaxel
Breakdown of trials Lawrence E. Feldman has run
Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lawrence E. Feldman specialize in?
Lawrence E. Feldman focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Lawrence E. Feldman currently recruiting for clinical trials?
Yes, Lawrence E. Feldman is currently recruiting for 9 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Lawrence E. Feldman has studied deeply?
Yes, Lawrence E. Feldman has studied treatments such as Pembrolizumab, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Lawrence E. Feldman?
Apply for one of the trials that Lawrence E. Feldman is conducting.
What is the office address of Lawrence E. Feldman?
The office of Lawrence E. Feldman is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.